State Agencies Sharpen Supplement Market Oversight During Pandemic, With Industry's Thanks
Executive Summary
"We're particularly concerned about the health care area right now because obviously that's driving everything now," says Tennessee AG Herbert Slatery III. He and CRN CEO Steve Mister spoke with HBW Insight about regulation of the consumer health marketplace with FDA suspending inspections of facilities operated by businesses manufacturing and marketing products subject to its oversight.
You may also be interested in...
For Inspection Restart, US FDA Urged To Prioritize Foreign Supply Chains, Uninspected Sites
CRN “urges FDA to pay special attention to international supply chains, ingredient identity and purity validation,” and CHPA suggests it make progress on facilities it has not previously inspected.
Silver Supplement’s Prayer For Immunity Not Answered By Industry Self-Regulation Ad Claim Review
BBB National Programs requested support for immunity boosting and safety claims televangelist Jim Bakker made for Optivida Silver Solution Liquid Solution in a video selling the product “as a treatment or cure for novel coronavirus or COVID-19."
Consumer Health Fraud: Collidial Silver A Pandemic Repeat Offender
COVID-19 makes silver a gift that keeps on giving for US regulators with another business closed by court order; Seattle area naturopath charged with selling misbranded drug as a virus prevention; FTC reaches settlements with operators of “free trial” schemes for cosmetics and supplements; FDA announces criminal convictions of two men who defrauded the agency by misbranding steroid drugs they sold OTC.